Current Vascular Pharmacology
Title:Editorial: The microRNA 221/222 Cluster: Inaugurating a New Era in Cardiovascular Disease and Cancer?
Volume: 15 Issue: 1
Author(s): Konstantinos Imprialos, Doumas M., Maria Tokamani, Raphael Sandaltzopoulos and Vasilios G. Athyros
Affiliation:
Export Options
About this article
Cite this article as:
Imprialos Konstantinos, M. Doumas, Tokamani Maria, Sandaltzopoulos Raphael and Athyros G. Vasilios, Editorial: The microRNA 221/222 Cluster: Inaugurating a New Era in Cardiovascular Disease and Cancer?, Current Vascular Pharmacology 2017; 15 (1) . https://dx.doi.org/10.2174/1381612822999161003224442
DOI https://dx.doi.org/10.2174/1381612822999161003224442 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Resistin and Cardiovascular Disease: A Review of the Current Literature
Regarding Clinical and Pathological Relationships
Current Cardiology Reviews Autoimmune Pancreatitis and Diagnostic Criteria
Current Immunology Reviews (Discontinued) Encephalopathy: A Vicious Cascade Following Forebrain Ischemia and Hypoxia
Central Nervous System Agents in Medicinal Chemistry Diabetic Heart and the Cardiovascular Surgeon
Cardiovascular & Hematological Disorders-Drug Targets The Imaging of Apoptosis with the Radiolabelled Annexin A5: A New Tool in Translational Research
Current Clinical Pharmacology miR-666-3p Mediates the Protective Effects of Mesenchymal Stem Cell-derived Exosomes Against Oxygen-glucose Deprivation and Reoxygenation- induced Cell Injury in Brain Microvascular Endothelial Cells via Mitogen-activated Protein Kinase Pathway
Current Neurovascular Research Acute Cardioembolic Cerebral Infarction: Answers to Clinical Questions
Current Cardiology Reviews Collagenolytic Enzymes and their Applications in Biomedicine
Current Medicinal Chemistry Rac-1 as a New Therapeutic Target in Cerebro- and Cardio-Vascular Diseases
Current Drug Targets The Rise and Fall of NMDA Antagonists for Ischemic Stroke
Current Molecular Medicine Patent Foramen Ovale and Thromboembolic Complications
Current Pharmaceutical Design Reacting to Stress: Radical Cellular Pathways for Novel Drug Development
Current Neurovascular Research Management and Outcomes of Aortic Dissection in Pregnancy with Marfan Syndrome: A Systematic Review
Current Vascular Pharmacology Randomized Clinical Stroke Trials in 2006
Current Vascular Pharmacology Cholinergic Treatment of Traumatic Brain Injury
Current Drug Therapy Early Brain Injury or Vasospasm? An Overview of Common Mechanisms
Current Drug Targets Chymase Inhibitor As a Novel Therapeutic Strategy for Anti-Vascular Remodeling
Vascular Disease Prevention (Discontinued) Feasibility and Efficacy of Low-profile Visual Intraluminal Support Device: A Single Center Five-year Experience
Current Neurovascular Research Human Immunodeficiency Virus (HIV) and Stroke: Targets for Intervention
Infectious Disorders - Drug Targets Experimental Models of Abdominal Aortic Aneurysms: An Overview
Current Pharmaceutical Design